Duties include the management, as President of an international consulting firm, which specializes in GMP audits,Quality Assurance, Quality Control, Regulatory Affairs and Manufacturing of drugs and biologics with offices in Washington, D.C. MHA has been a major participant in the approval of the first two botanical drugs approved by the FDA and continues to work on new botanical drug applications for submission to the FDA.